CHEBI:49201 - anti-ulcer drug

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name anti-ulcer drug
ChEBI ID CHEBI:49201
Definition One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
Stars This entity has been manually annotated by the ChEBI Team.
Members of anti-ulcer drug Class Download as Tab-delimited, XML, SDF
cisapride
Mass :465.94500
Formula : C23H29ClFN3O4
pirenzepine
Mass :351.40230
Formula : C19H21N5O2
pantoprazole
Mass :383.37093
Formula : C16H15F2N3O4S
tridihexethyl
Mass :318.51668
Formula : C21H36NO
anisotropine methylbromide
Mass :362.34552
Formula : C17H32NO2.Br
homatropine methylbromide
Mass :370.28140
Formula : C17H24NO3.Br
pantoprazole sodium
Mass :405.35276
Formula : C16H14F2N3NaO4S
lansoprazole
Mass :369.36259
Formula : C16H14F3N3O2S
rabeprazole
Mass :359.44300
Formula : C18H21N3O3S
esomeprazole magnesium
Mass :713.12100
Formula : (C17H18N3O3S)2.Mg C34H36MgN6O6S2
ranitidine
Mass :314.40400
Formula : C13H22N4O3S
famotidine
Mass :337.44868
Formula : C8H15N7O2S3
succinic acid
Mass :118.08800
Formula : C4H6O4
nizatidine
Mass :331.45700
Formula : C12H21N5O2S2
proglumide
Mass :334.41000
Formula : C18H26N2O4
tiquizium
Mass :330.530
Formula : C19H24NS2
tiquizium bromide
Mass :410.430
Formula : C19H24NS2.Br
egualen sodium
Mass :300.34800
Formula : C15H17NaO3S C15H17O3S.Na
egualen
Mass :278.36700
Formula : C15H18O3S
sofalcone
Mass :450.531
Formula : C27H30O6
vedaprofen
Mass :282.377
Formula : C19H22O2
(11R,16S)-misoprostol
Mass :382.53410
Formula : C22H38O5
misoprostol
Definition : A diastereoisomeric mixture composed of approximately equal amounts of a double racemate of four of the sixteen possible diastereoisomers of methyl (13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate that is racemic prostaglandin E1 which is lacking the hydroxy group at position 15, but which has an additional hydroxy group at position 16. It is a synthetic prostaglandin E1 analogue, used in the treatment of gastric and duodenal ulcers. A weak abortifacient, it is also used for cervical ripening prior to surgical termination of pregnancy. The (11R,16S)-diastereoisomer is the pharmacologically active form.
eupatilin
Mass :344.31540
Formula : C18H16O7
plaunotol
Mass :306.48280
Formula : C20H34O2
Yosprala
Definition : A mixture composed of acetylsalicylic acid (aspirin) and omeprazole (trade name Yosprala) that is used for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers.
esomeprazole
Mass :345.41600
Formula : C17H19N3O3S
cimetidine hydrochloride
Mass :288.80112
Formula : C10H16N6S.HCl C10H17ClN6S
cimetidine
Mass :252.34048
Formula : C10H16N6S
omeprazole
Definition : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
cetraxate
Mass :305.36886
Formula : C17H23NO4
teprenone
Mass :330.54720
Formula : C23H38O
rohitukine
Mass :305.330
Formula : C16H19NO5
pifarnine
Mass :424.629
Formula : C27H40N2O2
alpha-methylene gamma-butyrolactone
Mass :98.09990
Formula : C5H6O2
oxmetidine
Mass :399.46700
Formula : C19H21N5O3S
amlexanox
Mass :298.29340
Formula : C16H14N2O4
balsalazide
Mass :357.31750
Formula : C17H15N3O6
balsalazide disodium
Mass :437.31170
Formula : C17H17N3Na2O8
16,16-dimethylprostaglandin E2
Mass :380.519
Formula : C22H36O5
pibutidine
Mass :356.426
Formula : C19H24N4O3
pibutidine hydrochloride
Mass :392.880
Formula : C19H24N4O3.ClH
Graph View Tree View
panning
Move up
Move left
Move down
Move right
Graph compression

Simplified view Show me the possible minimal nodes in this graph
Full view Show me all the nodes in this graph
Personalised view Create your own personalised ontology view, if you wish to remove any entity from your future visualisations please right click the entity (e.g. molecular entity)
My hidden entities
Edit
+Zoom in
-Zoom out
Download
Enter fullscreen